ARCHIVED - Telecom - Commission Letter - 8678-C12-10/01 - Implementation of pricecap regulation for TELUS Québec and Télébec (Public Notice CRTC 2001-36) -Seeking comments on scope of public hearing
This page has been archived on the Web
Information identified as archived on the Web is for reference, research or recordkeeping purposes. Archived Decisions, Notices and Orders (DNOs) remain in effect except to the extent they are amended or reversed by the Commission, a court, or the government. The text of archived information has not been altered or updated after the date of archiving. Changes to DNOs are published as “dashes” to the original DNO number. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
LetterOur file: 8678-C12-10/01
Ottawa, 25 September 2001
To: Interested Parties
Re: Implementation of price cap regulation for TELUS Québec and Télébec (Public Notice CRTC 2001-36) - Seeking comments on scope of public hearing
As indicated in the letter dated 3 August 2001, a letter relating to the organization and conduct of the hearing including the scope of the cross-examination will be issued prior to the commencement of the oral hearing scheduled to commence on 13 November 2001. The first part of the oral hearing will be reserved for comments from the general public, with cross-examination of expert witnesses commencing thereafter. While there are a number of issues that have been raised as part of this proceeding, the Commission may wish to limit the scope of the cross-examination phase of the hearing. In order to determine the scope of the cross-examination, interested parties are asked to comment as to what issues should be pursued during the cross-examination phase of the public hearing.
Where a document is to be filed or served by a specific date, the document must be actually received, not merely sent, by that date.
c.c.: Claude Rousseau, CRTC, (819) 997-4605
Questions regarding procedure or electronic information should be addressed to:
- Date modified: